Skip to content

Citius Oncology, Inc. CTOR Repayments Of Notes Payable

Repayments Of Notes Payable at other companies

American Assets Trust logo
American Assets TrustAAT
$0-100%
Ascent Industries Co. logo
Ascent Industries Co.ACNT
$326K+20.3%
CTO
Citius Oncology, Inc.CTOR
$20M-60.0%
Century Communities logo
Century CommunitiesCCS
$9M+15.6%
RGC Resources logo
RGC ResourcesRGCO
$711.5K-84.3%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$305K+4,107%

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s repayments of notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s repayments of notes payable?
Citius Oncology, Inc. (CTOR) reported repayments of notes payable of $20M in Q3 2025.